What are the intramuscular (IM) and intravenous (IV) doses of succinylcholine for a pediatric patient with laryngospasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Succinylcholine Dosing for Pediatric Laryngospasm

For pediatric laryngospasm, administer succinylcholine 2 mg/kg IV for infants and small children, or 1 mg/kg IV for older children and adolescents; if IV access is unavailable, give 3-4 mg/kg IM (maximum 150 mg total dose). 1

Intravenous Dosing

The IV route is preferred when access is available, as it provides the most rapid onset (approximately 1 minute to neuromuscular blockade). 1

Age-Specific IV Dosing:

  • Infants and small pediatric patients: 2 mg/kg IV 1
  • Older pediatric patients and adolescents: 1 mg/kg IV 1
  • Neonates and infants up to 6 months: May require 2-3 mg/kg IV 1
  • Infants up to 2 years: May require 1-2 mg/kg IV 1

The American Academy of Pediatrics provides similar age-stratified recommendations: <1 month: 1.8 mg/kg, 1 month to 1 year: 2.0 mg/kg, 1-10 years: 1.2 mg/kg, >10 years: 1.0 mg/kg 2, 3

Intramuscular Dosing (When IV Access Unavailable)

When a suitable vein is inaccessible during laryngospasm, administer succinylcholine 3-4 mg/kg IM, with a maximum total dose of 150 mg. 1

IM Administration Details:

  • Onset time: Approximately 2-3 minutes 1
  • Maximum dose: Do not exceed 150 mg total 1
  • Clinical effectiveness: Despite slower onset compared to IV, clinical experience demonstrates satisfactory results for treating laryngospasm 4

Alternative IM Routes:

  • Intralingual/submental approach: May be considered with digital massage of injection site, which can reduce time to effect (mean 133 seconds vs 265 seconds without massage) 5
  • Intraosseous route: Probably superior to IM and comparable to IV in terms of onset time 4

Critical Management Considerations

Airway Management is Primary:

Before administering any medication, attempt basic airway maneuvers: 6

  • Apply 100% oxygen
  • Perform jaw thrust and gentle positive pressure ventilation
  • Consider gentle chest compression technique (73.9% success rate in relieving laryngospasm without medication) 7

When Succinylcholine is Contraindicated:

If succinylcholine cannot be used, rocuronium 1.0 mg/kg IM may provide an alternative, though with slower onset. 8 One case report demonstrated successful treatment of pediatric laryngospasm with IM rocuronium 1.0 mg/kg, achieving mask ventilation within one minute 8

Essential Safety Precautions:

  • Have atropine immediately available to prevent bradycardia, especially in children 2
  • Be prepared for immediate intubation and ventilatory support 2
  • Monitor for hyperkalemia risk in patients with undiagnosed myopathies, particularly boys <9 years old 2
  • Ensure dantrolene availability for malignant hyperthermia treatment 2

Common Pitfalls to Avoid

  • Do not underdose: Pediatric patients often require higher weight-based doses than adults due to larger volume of distribution 1
  • Do not delay IM administration: If IV access is not immediately available and laryngospasm persists despite airway maneuvers, administer IM succinylcholine promptly rather than continuing unsuccessful IV attempts 4
  • Do not forget post-treatment monitoring: Duration of hypoxia should be minimized; SpO2 <90% for >2 minutes increases risk of complications 8
  • Do not mix with alkaline solutions: Succinylcholine is acidic (pH 3.0-4.5) and incompatible with solutions pH >8.5 1

Related Questions

What is the treatment for laryngospasm (involuntary contraction of the vocal cords) associated with cough?
How do you manage laryngospasm in patients, particularly those with a history of asthma or chronic obstructive pulmonary disease (COPD)?
In a case of laryngospasm during planned intubation where mask ventilation is impossible, should a provider use a neuromuscular blocker (such as succinylcholine) or wait for the induction medication (propofol) to wear off while trying to break the laryngospasm with additional propofol?
What is the first line of treatment for laryngospasm?
What is a suitable muscle relaxant for a pediatric patient?
Is it appropriate to discontinue pulse oximeter monitoring in a premature neonate (newborn) with a high aspiration risk and ongoing feeding difficulties, despite having no apneic events in the past 10 days?
What are the possible diagnoses for an adult over 30 years old, presenting with acute pain in the left iliac fossa, who is overweight?
Is increasing bumetanide from 2 mg twice daily to 3 mg twice daily an appropriate plan for a patient with decompensated heart failure, chronic normocytic anemia, thrombocytopenia, hypoalbuminemia, hyperbilirubinemia, and hyperglycemia, with worsening laboratory results, including elevated NT-proBNP (N-terminal pro b-type natriuretic peptide), and stable renal function?
What are the symptoms of laryngospasm in a healthy adult?
At what level of thrombocytosis (elevated platelet count) should investigations be initiated in an adult patient?
What is the appropriate diagnostic and treatment approach for a patient experiencing intermittent, non-positional upper limb discoloration, considering potential underlying conditions such as Raynaud's phenomenon or peripheral artery disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.